An Open Randomized Two-Way Cross-Over Comparative Bioavailability Study to Compare the Extent of Systemic Absorption of Estradiol After a Single Dose Treatment With Two 25 Mcg Estradiol Vaginal Tablet Formulations Administered in Postmenopausal Women With Vaginal Atrophy.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 04 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Mar 2010 New trial record